Schuler Amends Aspira Women's Health Stake
Ticker: AWHL · Form: SC 13D/A · Filed: 2024-07-11T00:00:00.000Z
Sentiment: neutral
Topics: 13D-amendment, shareholder-filing
Related Tickers: AWX
TL;DR
Schuler updated his Aspira Women's Health filing, watch for changes.
AI Summary
Jack W. Schuler, through an amendment filed on July 11, 2024, has updated his beneficial ownership of Aspira Women's Health Inc. common stock. The filing indicates a change in the reporting person's holdings, though specific new dollar amounts or exact share counts are not detailed in this amendment. The event triggering this filing occurred on July 9, 2024.
Why It Matters
This amendment signals a potential shift in a significant shareholder's position in Aspira Women's Health, which could influence market perception and stock movement.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D often indicate changes in a significant investor's strategy or holdings, which can introduce volatility.
Key Players & Entities
- Jack W. Schuler (person) — Reporting Person
- Aspira Women's Health Inc. (company) — Subject Company
- 0000908834-24-000177 (filing_id) — Accession Number
FAQ
What specific changes were made to Jack W. Schuler's beneficial ownership of Aspira Women's Health Inc. common stock in this amendment?
This amendment (No. 16) to the Schedule 13D does not specify the exact changes in share count or percentage of beneficial ownership, but indicates an update to the reporting person's holdings.
When was the event that required this filing to be made?
The date of the event which requires filing of this statement is July 9, 2024.
What is the CUSIP number for Aspira Women's Health Inc. common stock?
The CUSIP number for Aspira Women's Health Inc. common stock is 04537Y208.
What is the business address of Aspira Women's Health Inc.?
The business address of Aspira Women's Health Inc. is 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.
Who is authorized to receive notices and communications for this filing?
Jack W. Schuler, located at PO Box 531, Lake Bluff, IL 60044, is the person authorized to receive notices and communications.
From the Filing
0000908834-24-000177.txt : 20240711 0000908834-24-000177.hdr.sgml : 20240711 20240711171426 ACCESSION NUMBER: 0000908834-24-000177 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240711 DATE AS OF CHANGE: 20240711 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60711 FILM NUMBER: 241112670 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SCHULER JACK W CENTRAL INDEX KEY: 0001021412 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: PO BOX 531 CITY: LAKE BLUFF STATE: IL ZIP: 60044 SC 13D/A 1 awh_13da.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC  20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 16) * Aspira Women's Health Inc. (Name of Issuer)   Common Stock, par value $0.001 per share (Title of Class of Securities)   04537Y208 (Cusip Number)   Jack W. Schuler PO Box 531 Lake Bluff IL 60044 (520) 906-2991 (Name, Address, and Telephone Number of Person Authorized to Receive Notices and Communications)   July 9, 2024 (Date of Event which Requires Filing of this Statement)   If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [   ] . Note:   Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Section 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes. (Continued on following pages) Page 1 of 7 Pages Exhibit Index Found on Page 7 13D CUSIP No.   04537Y208   1 NAMES OF REPORTING PERSONS   Jack W. Schuler 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)